Wells Fargo & Company Celcuity Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Celcuity Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,539 shares of CELC stock, worth $113,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,539

Previous 7,647 11.66%

Holding current value

$113,227

Previous $125,000 1.6%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.98 - $19.15 $12,470 - $17,081	892 Added 11.66%	8,539 $127,000
Q2 2024 Aug 13, 2024	BUY	$14.1 - $20.78 $17,230 - $25,393	1,222 Added 19.02%	7,647 $125,000
Q1 2024 May 10, 2024	BUY	$13.74 - $21.6 $14,880 - $23,392	1,083 Added 20.27%	6,425 $138,000
Q4 2023 Feb 09, 2024	BUY	$8.7 - $15.02 $9,230 - $15,936	1,061 Added 24.78%	5,342 $77,000
Q3 2023 Nov 13, 2023	SELL	$8.96 - $10.75 $20,177 - $24,209	-2,252 Reduced 34.47%	4,281 $39,000
Q2 2023 Aug 15, 2023	BUY	$9.39 - $12.18 $60,518 - $78,500	6,445 Added 7323.86%	6,533 $71,000
Q1 2023 May 12, 2023	BUY	$9.4 - $12.82 $404 - $551	43 Added 95.56%	88 $0
Q4 2022 Feb 13, 2023	SELL	$7.55 - $14.01 $520,731 - $966,283	-68,971 Reduced 99.93%	45 $0
Q3 2022 Nov 14, 2022	SELL	$8.0 - $10.64 $364,264 - $484,471	-45,533 Reduced 39.75%	69,016 $692,000
Q2 2022 Aug 12, 2022	SELL	$5.35 - $10.11 $841,266 - $1.59 Million	-157,246 Reduced 57.85%	114,549 $1.04 Million
Q1 2022 May 16, 2022	BUY	$7.93 - $13.33 $433,739 - $729,097	54,696 Added 25.19%	271,795 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$11.96 - $19.35 $192,376 - $311,244	16,085 Added 8.0%	217,099 $2.86 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $24.87 $2.27 Million - $3.26 Million	130,982 Added 187.03%	201,014 $3.62 Million
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $997,272 - $2.16 Million	69,984 Added 145800.0%	70,032 $1.68 Million
Q1 2021 May 13, 2021	BUY	$10.43 - $17.8 $156 - $267	15 Added 45.45%	48 $1,000
Q4 2020 Feb 09, 2021	SELL	$5.13 - $11.72 $2,436 - $5,567	-475 Reduced 93.5%	33 $0
Q3 2020 Nov 05, 2020	SELL	$5.1 - $7.07 $2,789 - $3,867	-547 Reduced 51.85%	508 $3,000
Q2 2020 Aug 13, 2020	SELL	$4.42 - $11.04 $61,641 - $153,963	-13,946 Reduced 92.97%	1,055 $7,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.78 $86,855 - $176,711	15,001 New	15,001 $97,000

Others Institutions Holding CELC

# of Institutions

107

Shares Held

30.3M

Call Options Held

30.8K

Put Options Held

152K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $198M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Celcuity Inc. Transaction History